You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 159 No. 20, November 8, 1999 TABLE OF CONTENTS
  Archives
  •  Online Features
  Editor's Correspondence
 This Article
 •Full text
 •PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citing articles on HighWire
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal

Neurocardiogenic Syncope and Cancer: A Paraneoplastic Association?

Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

I read with interest the article by Vloka et al1 that was recently published in the ARCHIVES. I would like to add to their interesting correlations between neurocardiogenic syndrome and other conditions; we recently reported2 the same syndrome accompanied by Prinzmetal angina and bronchogenic carcinoma. At the time of that report, we saw a patient with severe, recent-onset, crescendo, life-threatening manifestations of neurogenic imbalance that were totally and immediately relieved by administration of a chemotherapeutic agent. At 2-year follow-up, this patient is clinically free of disease (carcinoma) and totally asymptomatic for syncope, angina, and arrhythmias and is not receiving any medication.

We postulated that this patient's carcinoma was able to produce the cardiovascular manifestations by means of paraneoplastic activity and concluded that a history of newly developed neurocardiogenic syndrome in an older patient should alert the cardiologist to the possibility of a paraneoplastic syndrome.

I believe that the first patient . . . [Full Text of this Article]



THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Herbal medicines for treatment of bacterial infections: a review of controlled clinical trials
Martin and Ernst
J Antimicrob Chemother 2003;51:241-246.
ABSTRACT | FULL TEXT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1999 American Medical Association. All Rights Reserved.